U.S. Senator Tammy Baldwin Calls on President Trump to Provide Information on Political Appointees Serving in Key Drug Policy Positions
Letter to President Follows Report that 24-Year-Old with No Relevant Work Experience Served as Deputy Chief of Staff at the White House Office of National Drug Control Policy
Senators Also Call on President to Nominate Qualified Individuals to Lead the Office of National Drug Control Policy and Drug Enforcement Administration
WASHINGTON – Following reports that a 24-year-old with no relevant work experience served as Deputy Chief of Staff for the White House Office of National Drug Control Policy (ONDCP), U.S. Senator Tammy Baldwin joined her colleagues in calling on President Trump to provide information on all political appointees serving in key drug policy positions, including those appointees’ relevant qualifications.
The letter, which was led by Senator Maggie Hassan (D-NH) and signed by Senators Catherine Cortez Masto (D-NV), Ed Markey (D-MA), Sherrod Brown (D-OH), Dianne Feinstein (D-CA), Jeanne Shaheen (D-NH), Sheldon Whitehouse (D-RI), Richard Blumenthal (D-CT), and Elizabeth Warren (D-MA), additionally called on the President to identify, nominate and confirm qualified leadership to ONDCP and the Drug Enforcement Administration (DEA) with an urgency that matches the current crisis.
“As troubled as we are by [Taylor] Weyeneth’s appointment, your delay in nominating qualified leaders for ONDCP and the Drug Enforcement Administration (DEA) is even more concerning. Both agencies have been without permanent, Senate-confirmed leadership since you took office – and you have not presented the Senate with qualified candidates for these positions,” the Senators wrote.
The Senators added, “You have claimed that that the opioid epidemic is a top priority for your administration, but the personnel you have staffing these key agencies – and the lack of nominees to head them – is cause for deep concern. This crisis knows no bounds, and we are committed to working across party lines with anyone who is serious about addressing this devastating epidemic.”
The full letter is available here and below:
January 17, 2018
President Donald Trump
The White House
1600 Pennsylvania Avenue, NW
Washington, D.C. 20500
Dear President Trump:
We write to express our extreme concern regarding your seeming lack of commitment to the White House Office of National Drug Control Policy (ONDCP), which plays a critical role in coordinating the federal government’s response to the fentanyl, heroin and opioid epidemic.
On January 14, the Washington Post reported on Taylor Weyeneth, a 24-year-old political appointee who served as Deputy Chief of Staff for ONDCP, despite his complete lack of drug policy experience. Weyeneth had no relevant work experience and only held one full-time job prior to joining the administration – working for the Trump campaign.
As troubled as we are by Weyeneth’s appointment, your delay in nominating qualified leaders for ONDCP and the Drug Enforcement Administration (DEA) is even more concerning. Both agencies have been without permanent, Senate-confirmed leadership since you took office – and you have not presented the Senate with qualified candidates for these positions. Your first nominee to lead ONDCP withdrew his nomination following severe criticism over his close ties to the pharmaceutical industry, and you have yet to put forward a nominee to lead the DEA. We appreciate the work of the civil servants who are serving as acting heads of ONDCP and DEA, but acting leaders cannot enact the kind of robust response to the ongoing fentanyl, heroin and opioid epidemic that the crisis demands.
You have claimed that the opioid epidemic is a top priority for your administration, but the personnel you have staffing these key agencies – and the lack of nominees to head them – is cause for deep concern. This crisis knows no bounds, and we are committed to working across party lines with anyone who is serious about addressing this devastating epidemic. We hope to work with you, beginning with confirming qualified personnel to these key agencies. To that end, we request that you:
1. Provide our offices with a list of your political appointees to key drug policy positions and those appointees’ relevant qualifications, including appointees at ONDCP; the Department of Justice, including the DEA; the Substance Abuse and Mental Health Services Administration (SAMHSA); and elsewhere in your administration; and
2. Work with the Senate to nominate and confirm qualified leadership to ONDCP and DEA with an urgency that matches the current crisis, including considering hard-working civil servants who are already in positions of leadership at these agencies.
We look forward to your prompt reply.
An online version of this release is available here.
- AG Kaul Highlights Need for Crime Lab Toxicology Positions, Technology to Address Evolving Drug Epidemic - Josh Kaul - Mar 10th, 2021
- A Medication Rescue for Opioid Overdoses - Corri Hess - Feb 22nd, 2021
- State Receives $10 million in Opioid Crisis Settlement - Jenny Peek - Feb 5th, 2021
- AG Kaul, Gov Evers Announce $573 Million Multistate Agreement with McKinsey & Company for “Turbocharging” the Opioid Epidemic with Purdue Pharma - Josh Kaul - Feb 4th, 2021
- Gov. Evers, DHS Announce Nearly $9 Million Awarded for Drug Treatment Services - Gov. Tony Evers - Jan 14th, 2021
- AG Kaul, Bipartisan AGs Push FDA to Examine Progress in Opioid Fight - Josh Kaul - Jan 11th, 2021
- Milwaukee County Surpasses Last Year’s Record Overdose Deaths - Edgar Mendez - Nov 27th, 2020
- Overdose Responders Struggle Against Rising Deaths - Edgar Mendez - Nov 20th, 2020
- Wisconsin Drug Take Back Collection 1st in the Country; Collects Nearly 90,000 lbs. of Unwanted Medications to Fight the Opioid Epidemic - Josh Kaul - Nov 9th, 2020
- Gov. Evers, DSPS Secretary-designee Crim Announce Wisconsin Enhanced Prescription Drug Monitoring Program Awarded Nearly $2 Million Grant - Gov. Tony Evers - Nov 2nd, 2020
Read more about Opioid Crisis here
Mentioned in This Press Release
Recent Press Releases by U.S. Sen. Tammy Baldwin
American Rescue Plan Includes $1.75 Billion for CDC to Expand and Improve Genetic Sequencing for Coronavirus Variants
New legislation builds on program that provides support to working families to access the internet; Aids workers and families that need broadband to find jobs and access health care, education and other services; Improves coordination and speeds up benefits